Panel The Big Picture Plenary Series track
AI in the Lab: Why Greater Efficiency Could Mean More Drugs, Not Fewer Scientists
Mon, Nov 9, 2026 · 5:00–5:45 PM CET The Big Picture Stage, Koelnmesse
About this session
AI promises faster, cheaper, more scalable R&D. But beyond AI-powered discovery, is it helping address the development bottleneck? More ideas, more targets and more clinic-optimized molecules could mean more drugs, but only with smart selection and streamlined clinical data generation. This panel will cover: - How AI is – and isn’t - changing clinical trials in pharma - Whether AI is disrupting the R&D eco-system (biotech vs pharma) - Where are the value hotspots for investors? - Will AI replace some scientists?
